Pulmonary Drug Delivery Techniques

Displaying 1 - 3 of 3CSV
Camillo, C., Russum, S., Benvenuto, L., & D’Ovidio, F. (2023). (1277) Bile Acids Are Not Only a Marker of Aspiration as They Stimulate Fibrosis and Derange Surfactant Homeostasis in Human Lung Cells. The Journal of Heart and Lung Transplantation, 42(4), S545. https://doi.org/10.1016/j.healun.2023.02.1487
Publication Date
Panettieri Jr, R. A., Camargo Jr, C. A., Cheema, T., El Bayadi, S. G., Fiel, S., Vila, T. M., Jain, R. G., Midwinter, D., Thomashow, B., Ludwig-Sengpiel, A., & Lipson, D. A. (2022). Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial. International Journal of Chronic Obstructive Pulmonary Disease, Volume 17, 2043–2052. https://doi.org/10.2147/copd.s367701
Publication Date
Nichols, D. P., Singh, P. K., Baines, A., Caverly, L. J., Chmiel, J. F., GIbson, R. L., Lascano, J., Morgan, S. J., Retsch-Bogart, G., Saiman, L., Sadeghi, H., Billings, J. L., Heltshe, S. L., Kirby, S., Kong, A., Nick, J. A., & Mayer-Hamblett, N. (2021). Testing the effects of combining azithromycin with inhaled tobramycin forP. aeruginosain cystic fibrosis: a randomised, controlled clinical trial. Thorax, 77(6), 581–588. https://doi.org/10.1136/thoraxjnl-2021-217782
Publication Date